These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18638172)

  • 1. Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies.
    O'Callaghan DS; McNeil K
    Int J Clin Pract Suppl; 2008 Jul; (160):29-31. PubMed ID: 18638172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary hypertension in left heart disease].
    Opitz CF; Gläser S; Ewert R
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S167-9. PubMed ID: 19718607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibitors for pulmonary hypertension.
    Bergot E; Magnier R; Zalcman G
    N Engl J Med; 2010 Feb; 362(6):559; author reply 560. PubMed ID: 20147727
    [No Abstract]   [Full Text] [Related]  

  • 4. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.
    Saxena A
    Indian Heart J; 2007; 59(4):299-301. PubMed ID: 19126933
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphodiesterase type 5 inhibition: a support of the left ventricular assist device bridge to transplant.
    Semigran MJ
    Circ Heart Fail; 2008 Nov; 1(4):211-2. PubMed ID: 19808293
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatments for pulmonary arterial hypertension.
    Liu C; Liu K; Ji Z; Liu G
    Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative administration of PDE-5 Inhibitors.
    Edwards AF; Roy RC
    J Clin Anesth; 2009 Mar; 21(2):149; author reply 149-50. PubMed ID: 19329023
    [No Abstract]   [Full Text] [Related]  

  • 11. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
    Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
    Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients.
    Tay EL; Geok-Mui MK; Poh-Hoon MC; Yip J
    Int J Cardiol; 2008 Apr; 125(3):416-7. PubMed ID: 17407795
    [No Abstract]   [Full Text] [Related]  

  • 13. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

  • 14. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
    Gupta A; Kerkar P
    Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil improves survival in idiopathic pulmonary arterial hypertension.
    Sastry BK; Raju BS; Narasimhan C; Prakash GS; Reddy NK; Ananad B
    Indian Heart J; 2007; 59(4):336-41. PubMed ID: 19126939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating heart failure with sildenafil.
    Blum A
    Congest Heart Fail; 2009; 15(4):181-5. PubMed ID: 19627292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of pulmonary hypertension in patients with congenital heart disease].
    Miera O; Farahwaschy B; Schulze-Neick I; Berger F
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S209-11. PubMed ID: 18814099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension and right ventricular failure in left ventricular systolic dysfunction.
    Di Salvo TG
    Curr Opin Cardiol; 2012 May; 27(3):262-72. PubMed ID: 22495594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent pulmonary hypertension in the newborn: therapeutic effect of sildenafil.
    Cruz-Blanquel A; Espinosa-Oropeza A; Romo-Hernández G; Carrillo-Alarcón L; Ponce-Monter H; Ortiz MI
    Proc West Pharmacol Soc; 2008; 51():73-7. PubMed ID: 19544683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.